Folate status in women of childbearing age with obesity: a review by Maffoni, S. et al.
Folate status in women of childbearing
age with obesity: a review
The Harvard community has made this
article openly available.  Please share  how
this access benefits you. Your story matters
Citation Maffoni, Silvia, Rachele De Giuseppe, Fatima Cody Stanford, and
Hellas Cena. 2017. “Folate Status in Women of Childbearing Age




Terms of Use This article was downloaded from Harvard University’s DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at http://
nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAA
Folate status in women of childbearing age with obesity: a review
Silvia Maffoni1, Rachele De Giuseppe1, Fatima Cody Stanford2 and Hellas Cena1*
1University of Pavia, Department of Public Health, Experimental and Forensic Medicine, Unit of Human Nutrition,
Pavia, Italy
2Department of Medicine and Pediatrics, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
Abstract
Several studies have described a positive association between elevated BMI and birth defects risk. Data on plasma concentration of folate in
pregnant women with obesity have shown values far below those recommended, regardless of diet, while folate levels should increase before
pregnancy to reduce neural tube defects. We report a descriptive review of the most recent studies (from 2005 to 2015) to evaluate folate status
through a population of women of childbearing age affected by obesity. The literature contains few studies, which present conﬂicting results
regarding folate status in non-pregnant women of childbearing age affected by obesity, and it appears that there is a modiﬁcation in folate
metabolism, with a reduction in plasma folate levels and an increase in erythrocyte folate uptake. In conclusion, the folate status in women of
childbearing age should be assessed by both plasma and erythrocyte levels to start a personalised and more adequate supplementation before
conception. Further studies need to be conducted in a larger population, which take into account variables that can affect folate metabolism,
such as dietary intake, lifestyle and genetic factors, oral contraceptives or other drug use, previous weight-loss programmes, or a history of
bariatric surgery.
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Introduction
Adequate dietary folate intake is essential for meeting the
requirements for the functioning of the human body(1).
Neural tube defects (NTD), well-known consequences of
folate deﬁciency, are the second most common cause of serious
birth defects and affect 0·2–10 per 1000 established pregnancies
worldwide. NTD result from a failure of the neural tube to close
properly within 4 weeks following conception. There is a heavy
burden of illness for both the mother and her offspring, with
lifelong clinical and economic consequences, which may be
prevented with adequate dietary folate intake(2). In 1960s, the
link between folate deﬁciency during pregnancy and fetal NTD
emerged for the ﬁrst time. Subsequently, it has been demon-
strated that maintaining plasma folate levels >15·9 nmol/l and
erythrocyte folate levels >906 nmol/l signiﬁcantly reduces the
incidence of NTD(3,4). Similarly, the latest scientiﬁc evidence
suggests that an erythrocyte folate concentration above
1000 nmol/l is required for optimal NTD prevention(2). A recent
meta-analysis also evaluated the impact of maternal plasma
folate levels during pregnancy on DNA methylation in new-
borns, which identiﬁed differences between genes implicated in
various developmental abnormalities other than NTD(5).
Folate is a water-soluble organic compound, which belongs to
the group of B vitamins. It is an essential micronutrient for the
synthesis of RNA and DNA for cell division and tissue growth, as
well as for methylation reactions and amino acid metabolism(1,6).
A low plasma folate measurement is the earliest indicator of
altered folate exposure because it reﬂects recent dietary intake
(i.e. short-term status) and is highly responsive to intervention
with folic acid. Erythrocyte folate is a sensitive indicator of long-
term folate status, representing the amount of folate that accu-
mulates in erythrocytes during erythropoiesis, thereby reﬂecting
folate status during the preceding 120 d (i.e. the half-life of
erythrocytes)(1).
Inadequate dietary intake of folate is one of the leading
causes of folate deﬁciency(1); other major causes include
increased requirements due to pregnancy or neoplastic diseases,
malabsorptive conditions, anti-folate drugs or other metabolic
inhibitors, and alcohol intake (which affects both folate intake and
absorption). Recent research indicates that exposure to UV light,
including the use of tanning beds, can lead to a folate deﬁciency,
particularly in vulnerable individuals, such as women who are
pregnant or of childbearing age with high sun exposures(7).
In 2004, the National Health and Nutrition Examination Survey
(NHANES) data found that increased BMI of women of child-
bearing age was associated with a lower plasma folate level(4).
Another study in a UK obstetric cohort found that lower folate
concentrations were associated with higher BMI, independently
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However, data regarding folate status in women of child-
bearing age affected by overweight/obesity are scarce.
Several studies(9–11) have described a positive association
between elevated BMI and risk of birth defects. Particularly,
Rasmussen et al.(12) reported that maternal obesity was associated
with a 1·7-fold increased risk of NTD and Carmichael et al.(9)
suggested that pre-pregnancy obesity and low-quality diet (asses-
sed by a ﬁfty-eight-item FFQ) were both important and complex
factors associated with an increased risk of several birth defects.
Data on plasma concentration of folate in pregnant women
with obesity have shown values below those recommended,
regardless of diet(8), and we know from authors like Mastroiacovo
& Leoncini(13) that folate levels should be higher before preg-
nancy to decrease the risk of infants with NTD, low birth weight,
preterm delivery and fetal growth retardation(14).
Therefore, it is important to understand how obesity may
affect folate metabolism from the pre-conception period to
pregnancy(15) and if this target needs speciﬁc recommendations
to reduce adverse health outcomes in future generations.
Based on these considerations, the present review aims to
report recently published research on this topic. We reviewed and
summarised studies, published between 2005 and 2015, which
assessed folate status in women of childbearing age (women
between the ages of 15 and 49 years according to the WHO and
Centers for Disease Control and Prevention (CDC))(16,17) with
overweight/obesity.
We believe that a proper review on folate status of
childbearing-age women with obesity will contribute to eluci-
date this important topic as well as raise awareness on
the nutritional needs of women with obesity, from weight
management before conception, to clinical practice guidelines
targeted to address speciﬁc requirements for optimal nutrition
in pregnancy through an adequate and attentive health policy.
Materials and methods
The search strategy was conducted to identify studies that
examined the relationship between obesity and folic acid status
in women of childbearing age.
We conducted a detailed literature search in English to
identify all the studies performed from 2005 to 2015. The
following electronic databases were searched: PubMed, Scopus,
EMBASE and Web of Science.
The full electronic search strategy used was ‘folic acid’ OR
‘folate’ restricted to either ‘Medical Subject Headings (MeSH®)
major topic’/‘Emtree term’ of the article (PubMed and EMBASE,
respectively) or restricted to ‘Topic’/‘Article title, Abstract, key-
words’ of the article (Web of Science and Scopus, respectively)
AND ‘obese women’ restricted to title/abstract.
An initial search of English-language publications of the period
2005–2015, retrieved sixteen (PubMed), ten (Scopus), twelve
(EMBASE) and twenty (Web of Science) titles and abstracts.
Studies that met the following criteria were included:
(a) original study published in a peer-review journal; (b) studies
conducted in the last 10 years; (c) case–control studies, cohort
studies, randomised controlled trials, and meta-analyses;
(d) women with obesity of childbearing age; and (e) reported
data about concentration or metabolism of folate.
The exclusion criteria included duplicate studies, abstracts
from unpublished studies, reviews, case reports, letters,
studies without plasma concentration of folate, and studies
on postmenopausal populations.
Results
According to our inclusion and exclusion criteria, we selected
eight different studies (four case–control studies, one epide-
miological study, one retrospective cohort study and two
observational studies) conducted on women of childbearing
age with obesity. We evaluated the possible relationship
between obesity and folate deﬁciency and, as consequence,
the risk of NTD during pregnancy.
The observational study conducted by Hirsch et al.(18)
investigated whether there was an association between plasma
folate and total homocysteine levels and the presence of non-
alcoholic fatty liver disease in forty-three Chilean women, BMI
≥ 35 kg/m2, and age range 25–53 years, before undergoing
bariatric surgery and liver biopsy. For each patient, liver biop-
sies were graded for the presence of fat, inﬂammation and
ﬁbrosis on a scale from 0 to 3. Since the implementation of a
national programme which replaced traditional ﬂour in Chile
with folic acid-fortiﬁed ﬂour (200 µg folic acid per 100 g) in
2000, the study population showed plasma folate levels above
the cut-off value (>6·8 nmol/l). However, the authors reported
that mean plasma folate levels were signiﬁcantly (P= 0·005)
lower in patients with severe non-alcoholic fatty liver disease
(21·1 (SD 7·9) nmol/l) than in those with minimal or without liver
damage (27·7 (SD 7·04) nmol/l). An inverse and signiﬁcant
correlation between plasma folate levels and BMI was observed
(r –0·31; P= 0·046).
In a case–control study conducted by Ortega et al.(19), the
authors investigated the effect of two slightly hypoenergetic
dietary interventions on plasma folate levels among sixty-seven
Spanish young women (age range 20–35 years) with overweight/
obesity. Folate and other nutrient intakes were assessed by
means of a food diary kept over 3d; particularly, folate intake was
recorded in the form of dietary folate equivalents. Tobacco use,
alcohol and folic acid supplementation and/or fortiﬁed food
consumption were also investigated. At baseline, the mean folate
intake was far below the recommended 400 µg/d according to
the recommended daily intakes of energy and nutrients for
the Spanish population(19). Considering plasma folate levels at
baseline, 1·6% of the study population had plasma folate
levels <6·8nmol/l (high risk of folate deﬁciency cut-off value,
as reported by Wartanowicz et al.(20)) and about 45% of the
sample <14·9nmol/l (optimum status cut-off value, as reported
by Wartanowicz et al.(20)). Additionally, only 62·1% of the
study population had plasma folate concentrations above
≥13·6nmol/l, which was considered the lower limit of the range
of plasma folate concentrations associated with very low risk for
NTD, as reported by Sauberlich et al.(21). No results were reported
about the effect of tobacco use and alcohol consumption on
folate levels while no signiﬁcant differences were observed in the
plasma baseline folate levels between those who had taken and
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Subsequently, Stern et al.(22) conducted a case–control study
in order to compare pharmacokinetics of a single-dose folic
acid supplementation in twelve women affected by obesity v.
twelve normal-weight women of childbearing age (18–45 years
old). At baseline, the study population reported plasma folate
levels over the cut-off value (>15·9 nmol/l) and median plasma
folate levels did not differ signiﬁcantly (P= 0·94) between
women with or without obesity (median 21·6 (range 12·1–
46·3) nmol/l and 23·1 (range 9·4–44·1) nmol/l, respectively).
After oral folic acid supplementation (doses ranged from 0·0153
to 0·0917mg/kg), plasma folate levels were assessed in the
subsequent 10 h (0·5, 1, 2, 3, 4, 6, 8 and 10 h). Through statistical
analysis, it was found that folic acid does not freely distribute
into adipose tissue, probably secondary to its dependence on
lean body weight (LBW). Individuals with obesity not only
weigh more and have extra body fat, but they also have more
lean mass. Consequentely, peri-conceptional supplementation
recommendations may need to be adjusted to account for LBW
differences in the population with obesity due to its likely
impact on folic acid pharmacokinetics.
Ruiz-Tovar et al.(23) performed a retrospective cohort study
evaluating folate levels and other minerals and vitamins on thirty
female patients with morbid obesity (mean age 47·7 SD8·8) years;
range 20–62 years) who had undergone a laparoscopic sleeve
gastrectomy. These patients were assessed at baseline, and at 1,
3, 6, 9, 12, 18 and 24 months post-surgery. The authors reported
mean plasma folate levels of 8·3ng/ml. Folate deﬁciency
occurred in only one patient (3·3% of the study population).
The case–control study by Baltaci et al.(24) assessed plasma
folate levels in 116 female subjects with obesity (mean age
37·7 (SD 9·1) years) and 103 aged-matched healthy lean
women. The authors reported no signiﬁcant difference in mean
folate concentrations between women with or without obesity
(8·9 (SD 6·7) pg/ml; 6·8 (SD 3·3) pg/ml, respectively; P= 0·06)
and between those with or without the metabolic syndrome
(9·1 (SD 7·8) pg/ml; 8·4 (SD 3·9) pg/ml, respectively; P> 0·05).
Tinker et al.(25) analysed the data from the National Health
and Nutrition Examination Survey (NHANES), representative of
the non-institutionalised civilian US population, to assess if
BMI (normal-weight, overweight, and obesity categories) was
associated with changes in the correlation between folic acid
supplementation and folate status. The authors estimated the
geometric mean concentration among non-pregnant women of
childbearing age (4272 women, aged 15–44 years) of plasma
folate (period 2003–2008), erythrocyte folate (period 2007–2008)
and plasma total homocysteine (tHcy; period 2003–2006),
adjusting for age, race and ethnicity, and total dietary folate for
strata of supplement use and BMI (normal weight; overweight;
obesity). The authors reported that BMI was inversely associated
with plasma folate among women who did not use supplements
containing folic acid. In fact, plasma folate levels were sig-
niﬁcantly lower in women with obesity rather than in women
with BMI in the overweight or normal range (15·0, 16·0 and
16·4 ng/ml, respectively). Statistically, these signiﬁcant differ-
ences in the adjusted geometric mean concentrations of plasma
folate by BMI category were observed only among supplement
non-users while in each BMI category, supplement non-users
had signiﬁcantly lower adjusted geometric mean concentrations
of plasma folate than any category of supplement users.
On the contrary, the adjusted geometric mean concentration of
erythrocyte folate was higher among women with obesity rather
than women with normal weight or overweight, suggesting that
BMI may affect the body distribution of folate. Among both
supplement users and non-users, the adjusted geometric mean
erythrocyte folate concentrations were higher among women
with obesity while, within each BMI category, the adjusted
geometric mean concentration of erythrocyte folate was higher
among supplement users than non-users.
Da Silva et al.(15) analysed the relationship between BMI and
the short-term pharmacokinetic response to an oral dose of folic
acid. Sixteen healthy women with obesity and sixteen women
with normal weight of childbearing age (18–35 years) were
administered a single oral dose of folic acid (400 μg). Blood
samples were collected at baseline and after 10 h period. At
baseline they found lower plasma folate (P< 0·005) and higher
erythrocyte folate (P= 0·05) in the group with obesity; the
authors do not report if a folate status deﬁciency occurs through
the observed population; plasma folate reference interval and/
or cut-off values were not reported. The AUC for the absorption
phase (0–3 h), peak plasma folate concentrations and overall
plasma folate response (0–10 h) were lower in women with
obesity v. normal weight, suggesting that body distribution of
folate is signiﬁcantly affected by obesity.
Finally, De Luis et al.(26) analysed vitamin status (A, D, E, K, B12
and folate) as well as micronutrient status (Zn, Cu, phosphate, Ca)
in a group of 115 women with a mean age of 43 years with
morbid obesity, candidate to biliopancreatic diversion surgery;
although no distinction between women of childbearing age
and perimenopausal ones was reported, we included this study.
The recruited population was divided into four groups
(35≤BMI< 40kg/m2; 40≤BMI< 45kg/m2; 45≤BMI< 50kg/m2;
BMI ≥50kg/m2), with no differences in height and age. The
results of this observational study highlighted that plasma folate
levels were <3ng/ml in 25·2% of the sample; moreover no
association between BMI and folate levels was found(26).
Discussion
Obesity and excess weight during pregnancy are associated
with a number of complications during childbirth through the
inﬂuence on the intra-uterine growth of the fetus. There is an
increasing interest in nutritional status before and during
pregnancy as well as in nutrient intake and their effects on
offspring. Folate status in women with overweight/obesity may
be altered and may be a possible contributor in increasing the
risk of congenital birth defects, particularly NTD. A potential
hypofolataemia in fertile women affected by overweight/
obesity could be responsible for a higher risk of NTD in the
offspring. However, only a few studies have shown an interest
in analysing folate status in childbearing-age women with
overweight/obesity, and these results are discordant.
In fact, some reported studies showed suboptimum levels of
plasma folate in a high percentage of women with overweight
(45%)(19) and/or obesity (25·2%)(26) while others describe no
signiﬁcant difference in folate levels between the groups of
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Additionally, with regards to the positive association between
BMI and folate concentration, results are conﬂicting: some
authors described a positive association between BMI and
folate levels(19,26) while others did not(24,26). Finally, only two
studies evaluated plasma and erythrocyte folate concentration,
a measurement that could be very important as more
discussions ensue(15,25).
This heterogeneity of results could be due to several
methodological aspects and other unassessed factors, such as
level of education and socio-economic status(27), alcohol con-
sumption or drug intake(28), which might inﬂuence plasma and
erythrocyte folate levels and might help explain folate deﬁ-
ciency in women of childbearing age with overweight/obesity.
Folate deﬁciency deﬁnition
Objective data from the clinical laboratory are critical for
medical decisions, including initial diagnosis and monitoring
of treatment outcome. Laboratory errors, including inaccurate
reference intervals or cut-off values, can lead to inappropriate
diagnosis, unnecessary test repetitions and inappropriate
follow-up investigations. Moreover, excessively wide reference
intervals may mask subclinical disorders, and the use of incorrect
reference intervals or cut-off values may confuse the clinical
picture. Therefore, relevant reference intervals or cut-off values
are required for a correct test result interpretation(29).
An initial fall in plasma folate concentration below 6·8nmol/l
(3 ng/ml) followed by a progressive depletion of folate stores
trigger bone marrow to generate macrocytic cells with abnormal
nuclear maturation(6). Based on the microbiological Lactobacillus
casei subsp. rhamnosus assay, cut-off values for plasma and
erythrocyte folate deﬁciency have been set at 6·8nmol/l
(3 ng/ml) and 140ng/ml (317nmol/l), respectively(6).
Thakur et al.(30) reported that a subject is considered to
be folate deﬁcient if plasma and erythrocyte folate concentra-
tions are less than 2 and 150 ng/ml (4·5 and 340·9 nmol/l),
respectively.
Wartanowicz et al.(20) considered plasma folate levels
≥14·9 nmol/l as the optimum cut-off value, with plasma folate
levels ≥13·6 nmol/l as the lower limit of the range of plasma
folate concentration associated with very low risk for NTD.
In woman with overweight and obesity who are planning to
get pregnant, the use of this cut-off value might be more
appropriate in order to minimise the risk of NTD. Additionally,
experts(2,31,32) agree that erythrocyte folate levels above
1000 nmol/l are required for optimal NTD prevention.
The studies presented in this review reported different cut-off
values: Hirsch et al.(18) used a cut-off value of >6·8nmol/l; Ortega
et al.(19) stratiﬁed the population by using the cut-off values of
≥14·9 and ≥13·6nmol/l; Stern et al.(22) used a cut-off value of
>15·9nmol/l; De Luis et al.(26) used a cut-off value of >3ng/ml;
Ruiz-Tovar et al.(23), Baltaci et al.(24), Tinker et al.(25) and da Silva
et al.(15) did not specify the cut-off values considered.
Since the different cut-off values used to deﬁne plasma and
erythrocyte folate deﬁciency were not always reported in these
studies, the diagnosis of folate status deﬁciency in women with
obesity could lack uniformity.
Erythrocyte folate levels and supplementation
A single measurement of plasma/plasma folate provides little
information on the folate status and body stores(33). Erythrocyte
folate content is known to reﬂect long-term average con-
sumption and tissue stores since erythrocytes accumulate folate
merely during erythropoiesis(33).
Recent studies conducted on folic acid fortiﬁcation described a
paradoxical phenomenon. Obesity exhibits low fasting plasma
folate but high erythrocyte levels of folate(33). Additionally,
subjects with obesity reported higher levels of plasma folate
oxidation products (5-methyltetrahydrofolate oxidation product;
MeFox) than subjects without obesity because obesity is found to
be associated with increased activity of cytochrome P450 (CYP)
2E1, a mono-oxygenase enzyme that can use folic acid as a
substrate(33).
Tinker et al.(25) evaluated erythrocyte folate levels, suggesting
that erythrocyte folate concentration was higher among women
with obesity, particularly in the supplemented ones, while
plasma folate concentration was signiﬁcantly lower in those
with obesity compared with those with overweight or normal
weight. These ﬁndings were in agreement with previous
results(33). In fact, Zhou et al.(33) reported that dietary folate
deﬁciency led to a lower plasma folate concentration, up-
regulating trans-epithelial transport and enhancing cellular
uptake of the developing erythrocyte.
Stern et al.(22) sought to ﬁnd an explanation of why the folate
status of women with obesity differs compared with those
with normal weight or overweight, and they attributed it to the
differences in metabolism; in fact the area under the time–
concentration curve (AUC) was found to be signiﬁcantly higher in
those with obesity when deﬁned as a function of total body
weight, underlining that folate does not freely distribute into
adipose tissue. When the AUC was deﬁned as a function of dose
per kg of LBW, it was found to be signiﬁcantly higher in the group
with obesity (P= 0·008), with individuals with obesity having
higher weight and body fat but also more LBW. The author
concluded that peri-conceptional supplementation recommen-
dations might need to be adjusted to account for LBW differences
in the population with obesity, which provides initial evidence
that LBW, which also increases as total body weight does in
obesity, signiﬁcantly affects folic acid pharmacokinetics. Never-
theless, increased storage in erythrocyte levels does not mean
fetal safety from NTD since there could be ampliﬁed plasma
5-methyltetrahydrofolate oxidation products suggesting increased
degradation of folate(33).
Genetic factors
Some polymorphisms of genes encoding enzymes and trans-
port proteins involved in folate metabolism have an impact on
folate status and health consequences; it has been suggested
that the 677C→T polymorphism of the gene encoding the
methyltetrahydrofolate reductase (MTHFR) enzyme has the
highest impact on folate metabolism(6). MTHFR converts 5,10-
methylene-THF to 5-methyl-THF 785 providing one-carbon unit
for the methylation cycle. Homozygosity for the T allele is
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about 20–25% lower plasma folate and higher plasma total
homocysteine concentrations compared with the 677CC
genotype(6). Studies reported in the present review did not
evaluate this aspect.
Lifestyle factors
Lifestyle factors such as dietary intake, cigarette smoking and
alcohol intake affect folate status(30,34,35). Micronutrient
deﬁciencies (including folate) associated with overweight and
obesity may result from increased intake of relatively cheap,
energy-dense but nutrient-poor food(36), and folate levels might
be inﬂuenced by metabolism alteration, which can occur in
obesity(37). The recommended intake is 400 μg/d(38,39) and Stern
et al.(22) reported that women with a BMI indicative of obesity
(≥ 30 kg/m2) would need an additional 350 µg of folic acid per d
to reach a folate status analogous to those with a lower BMI.
Excessive alcohol(30) and coffee(40) consumption can also
lead to folate deﬁciency and, as concerns cigarette smoking,
several mechanisms (such as decreased dietary intake, reduced
absorption, diminished hepatic uptake, increased urinary
excretion, possible interaction between chemical components
of cigarette smoke and folate coenzymes) may explain folate
deﬁciency in smokers(34,41).
Oral contraceptives
Recently Shere et al.(42) conducted a systematic review and
meta-analysis on the effect of oral contraceptives on plasma
and erythrocyte folate concentrations to ascertain how the
reduction in blood folate concentrations is associated with oral
contraceptive use. No studies presented in this review have
considered oral contraceptive use.
Bariatric surgery and restrictive diet
Finally, weight loss induced by bariatric surgery is a major factor
implicated in folate status in childbearing-age women affected
by severe obesity. Bariatric surgery is increasingly performed
and evidence demonstrates that weight-loss surgeries lead to
greater beneﬁts than traditional weight-loss therapies among
subjects with severe obesity. However, some bariatric surgical
procedures may induce malabsorption and frequently result in
nutritional deﬁciencies, such as folate deﬁciency(43,44). Nutrient
deﬁciencies may also occur after restrictive surgical procedures,
such as adjustable gastric banding, because of decreased
food intake and dietary imbalances(44). Furthermore, even
unbalanced or very-low-energy diets may induce nutrient
deﬁciencies(45) because of poor nutrition or dietary restriction
that prevents meeting the requirements(46), leading to a
decreased folate intake, which is particularly risky in the peri-
conceptional period. On the other hand, hypoenergetic
balanced diets may also maintain or even improve folate status
either because they are rich in vegetables and fortiﬁed cereals,
or because weight loss per se may modify the folate metabolism
through a reduction in the erythrocytes’ uptake(15,22).
Clinical practice
As described in this review, there are relatively few and
discordant results regarding folate levels in women of child-
bearing age affected by overweight/obesity, and further studies
need to be conducted in the greater population, taking into
account the multiple variables that can affect folate metabolism.
Nevertheless, it is important to assess the folate status in women
of childbearing age with overweight/obesity who plan to
become pregnant to prevent NTD.
Non-pregnant women with obesity, including those of child-
bearing age, have shown lower plasma folate and higher
erythrocyte folate than normal-weight women. Since the
placenta takes up folate from the maternal plasma and the pla-
cental uptake of circulating folate ensures an adequate folate
supply to the developing fetus, low plasma folate in women with
obesity could increase the risk for NTD-affected pregnancy even
after adjustment for dietary and supplemental folate intake.
Women of childbearing age with obesity may therefore require
supplemental folic acid to increase or maintain a plasma folate
status that is associated with maximal protection from NTD(47).
Folate status should be assessed both by plasma and
erythrocyte levels and practitioners should take into account
several other factors such as dietary intake (fruit and vegetable
consumption and/or fortiﬁed foods and/or vitamin supple-
mentation), lifestyle factors (cigarette smoking and alcohol
consumption) and genetic factors, oral contraceptive use, and
previous weight-loss programmes or bariatric surgery.
Although major health organisations promote the use of folic
acid in women of reproductive age through clinical guidelines
and recommendations, the EuroPrevall study(48) has revealed
that maternal dietary habits as well as the use of dietary sup-
plements during pregnancy vary signiﬁcantly across Europe.
The authors suppose that communication is scarce and has a
low level of efﬁcacy, which suggests that further investigation
on dissemination of recommendations and on factors associated
with long-term compliance might be useful for improving
public health strategies to promote healthy pregnancies and
pregnancy outcomes.
Additionally, the prevalence of folic acid supplementation is
reported to be high in the prenatal period, while most women do
not use folic acid in the peri-conceptional period, even if they are
aware of the beneﬁts(49). Since it is estimated that approximately
one-third of pregnancies worldwide are unplanned and many
women may be unaware of their pregnancy for a few weeks
after conception, folic acid supplementation should be recom-
mended to all women of childbearing age, particularly to those
affected by overweight/obesity.
Recently, Cawley et al.(2), in a review of European guidelines
on peri-conceptional folic acid supplementation, reported that
400 μg folic acid pre-conceptional supplementation for at least
12 weeks is required to achieve optimal levels in erythrocytes to
prevent NTD.
Some might disagree with the need for folic acid fortiﬁcation
or supplementation since some studies suggest adverse health
outcomes; however, data are conﬂicting.
Studies connected asthma incidence in childhood with folic acid
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review was to alert the health care community about the need to
screen women at risk of folate deﬁciency in the pre-conceptional
period. Recently, systematic reviews and meta-analyses have
demonstrated a beneﬁcial or neutral effect in the aetiology of
cancer while in 2009 the European Food Safety Authority (EFSA)
Scientiﬁc Cooperation Working Group (ESCO WG) on ‘analysis
of risks and beneﬁts of fortiﬁcation of food with folic acid’ con-
cluded that there were currently insufﬁcient data to allow a full
quantitative risk assessment of folate status and cancer(46,52,53).
Conclusion
In conclusion, folate status in women with overweight/obesity
may be altered and may be a possible contributor in increasing
the risk of congenital birth defects, particularly NTD. However,
only a few studies have shown an interest in analysing folate
status in childbearing age women with overweight/obesity, and
results are conﬂicting. This heterogeneity of results could be
due to several methodological aspects and other unassessed
factors. Therefore, further studies need to be conducted in a
larger population, which take into account variables that can
affect folate metabolism, such as dietary intake, lifestyle and
genetic factors, oral contraceptives or other drug use, previous
weight-loss programmes, or a history of bariatric surgery.
Nevertheless, although results are so heterogeneous, and
further studies are mandatory, physicians should screen the
folate status in women of childbearing age both assessing
plasma and erythrocyte levels to start a personalised and more
adequate supplementation before conception. Women with
obesity, those with recent weight loss or who follow a low-
energy diet, and those who have an unhealthy lifestyle are most
at risk for folate deﬁciency and insufﬁciency.
Limitations
The studies considered in this review have some limitations that
should be acknowledged. First, study populations were small in
number and often had a wide age range. There are differences
in race/ethnicity and country of origin which should be
taken into consideration, since in some countries, especially in
Europe, there is no mandatory fortiﬁcation while the USA and
South America are regulated by different fortiﬁcation policies;
therefore data are not always comparable.
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